Retrochimera combines two deep learning algorithms from different classes, outperforming their individual success rates on datasets from Novartis and GSK
Bringing together two different AI models built to ‘think’ in entirely different ways reduces failures and hallucinations that can arise when they perform an important chemical task – retrosynthesis.
‘We find that different models have different strengths and that combining them can yield considerable performance improvements over any single model alone,’ says Marwin Segler, senior director at Microsoft Research AI for Science in Cambridge, UK. The combined tool, Retrochimera, can also be fine-tuned cheaply and quickly to work with new databases of reactions.